Effect of ryanodine on sarcoplasmic reticulum Ca2+ accumulation in nonfailing and failing human myocardium

Circulation

Volumn 92, Issue 9, 1995, Pages 2504-2510

  Nimer, Lynn R ^b   Needleman, Dolores H ^c   Hamilton, Susan L ^c   Krall, Judith ^b   Movsesian, Matthew A ^a,b,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Calcium; Calcium channels; Cardiomyopathy; Heart failure; Sarcoplasmic reticulum

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; RYANODINE; RYANODINE RECEPTOR;

ADULT; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM MOBILIZATION; CARDIOMYOPATHY; CONTROLLED STUDY; HEART FAILURE; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; MICROSOME; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM;

ADULT; CALCIUM; CALCIUM CHANNELS; HEART FAILURE, CONGESTIVE; HEART VENTRICLE; HUMAN; IN VITRO; MICROSOMES; MIDDLE AGE; RYANODINE; SARCOPLASMIC RETICULUM; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028882615     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.92.9.2504     Document Type: Article

References (44)

1. Movsesian MA. Calcium uptake and release by cardiac sarcoplasmic reticulum. In: Allen PD, Gwathmey JK, Briggs M, eds. Inotropic Drugs: Basic Mechanisms and Clinical Practice. New York, NY: Marcel Decker Inc; 1993:101-120.
2. Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W, Morgan JP. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res. 1987;61:70-76.
3. Beuckelmann DJ, Nabauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation. 1992;85:1046-1055.
4. 2+ uptake by cardiac sarcoplasmic reticulum from patients with idiopathic dilated cardiomyopathy. Circ Res. 1989;65:1141-1144.
5. 2+ uptake in sarcoplasmic reticulum from normal and failing hearts. J Clin Invest. 1990;85:1698-1702.
6. Movsesian MA, Smith CJ, Krall J, Bristow MR, Manganiello VC. Sarcoplasmic reticulum-associated cyclic adenosine 5′-monophosphate phosphodiesterase activity in normal and failing human hearts. J Clin Invest. 1991;88:15-19.
7. 2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation. 1994;90:653-657.
8. Movsesian MA, Leveille C, Krall J, Colyer J, Wang JH, Campbell KP. Identification and characterization of proteins in human cardiac sarcoplasmic reticulum. J Mol Cell Cardiol. 1990;22: 1477-1485.
9. 2+-ATPase in failing and nonfailing human myocardium. Circ Res. 1994;75:434-442.
10. 2+ exchanger in end-stage human heart failure. Circ Res. 1994;75:443-453.
11. Steenbergen C, Murphy E, Levy L, London RE. Elevation in cytosolic free calcium concentration in myocardial ischemia in perfused rat hearts. Circ Res. 1987;60:700-707.
12. 2+ uptake of cardiac sarcoplasmic reticulum. Circ Res. 1989;65: 1400-1408.
13. Davis MD, Lebolt W, Feher JJ. Reversibility of the effect of normothermic global ischemia on the ryanodine-sensitive and ryanodine-insensitive calcium uptake of cardiac sarcoplasmic reticulum. Circ Res. 1992;70:163-171.
14. 2+ release channel in isolated rat hearts. Circ Res. 1992;71:1049-1058.
15. Okabe E, Kasumi K, Tsukasa S, Naoaki S, Kazuyuki T, Haruo I. The effect of ryanodine on oxygen free radical-induced dysfunction of cardiac sarcoplasmic reticulum. J Pharmacol Exp Ther. 1991;256: 868-875.
16. Rardon DP, Dominic CC, Mitchell RD, Seiler SM, Hathaway DR, Jones LR. Digestion of cardiac and skeletal muscle junctional sar-coplasmic reticulum vesicles with calpain II. Circ Res. 1990;67: 84-96.
17. Fujii J, Otsu K, Zorzato F, de Leon S, Khana VK, Weiler JE, O'Brien PJ, MacLennan DH. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science. 1991;253:448-451.
18. 2+ release channel function in sarcoplasmic reticulum of pressureoverload-induced hypertrophic rat heart. J Mol Cell Cardiol. 1994; 26:1505-1512.
19. Naudin V, Oliviero P, Rannou F, Sainte-Beuve C, Charlemagne D. The density of ryanodine receptors decreases with pressure overload-induced rat cardiac hypertrophy. FEBS Lett. 1991;285: 135-138.
20. Dodd DA, Atkinson JB, Olson RD, Buck S, Cusack BJ, Fleischer S. Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sarcoplasmic reticulum in a chronic rabbit model. J Clin Invest. 1993;91:1697-1705.
21. Cory CR, McCutcheon LJ, O'Grady M, Pang AW, Geiger JD, O'Brien PJ. Compensatory downregulation of myocardial Ca channel in SR from dogs with heart failure. Am J Physiol. 1993;264: H926-H937.
22. Vatner DE, Sato N, Kiuchi K, Shannon RP, Vatner SF. Decrease in myocardial ryanodine receptors and altered excitation-contraction coupling early in the development of heart failure. Circ Res. 1994; 90:1423-1430.
23. Finkel MS, Shen L, Romeo RC, Oddis CV, Salama G. Radioligand binding and inotropic effects of ryanodine in the cardiomyopathic Syrian hamster. J Cardiovasc Pharmacol. 1992;19:610-617.
24. Sapp JL, Hewlett SE. Density of ryanodine receptors is increased in sarcoplasmic reticulum from prehypertrophic cardiomyopathic hamster heart. J Mol Cell Cardiol. 1994;26:325-334.
25. Lachnit WG, Phillips M, Gayman KJ, Pessah IN. Ryanodine and dihydropyridine binding patterns and ryanodine receptor mRNA levels in myopathic hamster heart. Am J Physiol. 1994;267: H1205-H1213.
26. Holmberg SRM, Williams AJ. Single channel recordings from human cardiac sarcoplasmic reticulum. Circ Res. 1989;65: 1445-1449.
27. Brillantes A-M, Allen P, Takahashi T, Izumo S, Marks AR. Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy. Circ Res. 1992;71:18-26.
28. 1-receptor down-regulation in heart failure. Circ Res. 1986;59:297-309.
29. 2+-pump from cardiac sarcoplasmic reticulum. Methods Enzymol. 1988;157: 107-154.
30. Fabiato A. Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands. Methods Enzymol. 1988;157:378-417.
31. Chu A, Diaz-Munoz M, Hawkes MJ, Brush K, Hamilton SH. Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel. Mol Pharmacol. 1990;37:735-741.
32. Cleland WW. Statistical analysis of enzyme kinetic data. Methods Enzymol. 1979;63:103-138.
33. 2+ release channel. J Biol Chem. 1993;268: 20974-20982.
34. Bradford MM. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
35. 2+ release channel complex. J Biol Chem. 1989;264:1329-1335.
36. Jones LR, Cala SE. Biochemical evidence for the functional heterogeneity of cardiac sarcoplasmic reticulum vesicles. J Biol Chem. 1981;256:11809-11818.
37. Ikemoto N, Ronjat M, Meszaros LG, Koshita M. Postulated role of calsequestrin in the regulation of calcium release from sarcoplasmic reticulum. Biochemistry. 1989;28:6764-6771.
38. Brillantes A-M, Ondrias K, Scott A, Kobrinsky E, Ondriasova E, Moschella MD, Jayaraman T, Landers M, Ehrlich BE, Marks AR. Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell. 1994;77:513-523.
39. Berridge MJ, Irvine RF. Inositol phosphates and cell signalling. Nature. 1989;341:197-205.
40. 2+ from permeabilized cardiac myocytes and sarcoplasmic reticulum. FEBS Lett. 1985;185:328-332.
41. Kijima Y, Saito A, Jetton TL, Magnuson MA, Fleischer S. Different intracellular localization of inositol 1,4,5-trisphosphate and ryanodine receptors in cardiomyocytes. J Biol Chem. 1993;268: 3499-3506.
42. 2+ release in rabbit skeletal muscle sarcoplasmic reticulum. FEBS Lett. 1993;330:270-274.
43. 2+ channel. Nature. 1993;364:76-79.
44. 2+-release channel. Circ Res. 1994;75: 596-600.